Gastric and duodenal ulcer is a chronic recurrent disease, the main symptom of which is formation of defect (ulcer) in the wall of stomach or duodenum.
There are several factors considered to cause this disease. Nowadays the most popular is helicobacter theory. However there are no doubts that this disease is induced by several triggering factors. Modern principles of drug therapy of gastric and duodenal ulcer do not differ radically. Anti-helicobacter therapy including antisecretory (omeprazole, ranitidine) and antimicrobial agents and antiacid preparations is recognized to be the basis of anti-relapsing therapy. Treatment of peptic ulcer is quite long-term and complex.
After use of EnergoIod condition of patients with gastritis and gastric and duodenal ulcer was improved on the 12th day due to the following effects of EnergoIod:
- Antibacterial effect which does not entail development of microorganisms’ resistibility and causes no harm to normal microflora;
- Immunosuppression is developed in acute conditions meanwhile EnergoIod Concentrate has immunocorrective effect;
- Antiinflammatory effect;
- Improvement of flow characteristics of blood, normalization of microcirculation, which ensures prompt recovery of ulcerous defects;
- Regenerative effect promoting recovery of ulcerous surface;
- Topical anesthetic effect;
- The preparation is nontoxic.
Terms of recovery are reduced after inclusion of EnergoIod in combination therapy. You’ll fell yourself better in 10-15 days. And you’ll be surprised after a month of treatment with EnergoIod.
Use of EnergoIod in This Disease
Use of EnergoIod in this disease
Weight, kg
For disease
Lung disease
Average disease
Severe disease
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
40
2
4
4
8
6
12
50-60
3
6
6
12
9
18
70-80
4
8
8
16
12
24
90-100
5
10
10
20
15
30
110-120
6
12
12
24
17
34
Use of a concentrate
Shake before use. It requires dilution with cold or cool drinking water (in an amount of 100-200 ml).
The daily dose calculated for 1 kg body weight, depending on the severity and course of the disease is 0.1-0.3 ml / kg body weight / day, divided into 2 doses.
The drug is taken on an empty stomach in the morning and in the evening before going to bed for 30 days.
If necessary, a second course in 15 days.
The number of courses per year depending on the severity of the pathological process.
Carrying out an accelerated rate with the maximum dose for 15 days.